Saturday, September 30, 2017

Vuzix - What the hell happened on Thursday?

If you're holding or watching Vuzix, which trades under the symbol VUZI, then you no doubt saw the wild trading that took place on Thursday September 28th.

The stock opened down at $5.60, but that was nothing compared to what was coming.  The stock crashed and traded as low as $4.10 inter-day, but by the close it recovered to the opening price of $5.60 for a 5 cent drop from the Wednesday close.  

Quite the roller coaster, or more like that drop zone amusement ride maybe...or better yet a bungee jump.  

Social media sites like StockTwits were rife with speculation as to the cause.  Some thought it was a bear attack, others put the blame on manipulation dropping the price so that accumulators could take out stop losses.  There were all manner of theories, and I can imagine it was probably a bit nerve wracking for some shareholders.  I figure there had to be some big players involved, the volume of almost 1.5 million is almost ten times more than the daily average for the preceding three months.

Of course assuming there were some big players working their magic, I don't expect they'll be announcing anything.  Don't expect to see some Hedge Fund type issuing a PR saying:

********************

Fake News Wire (FNW) September 30th 2017:
We at Bogus Hedge Fund were responsible for the increased volume and volatility in the trading of VUZI shares on Thursday Sept 28th.  We engaged in what is commonly called a "Bear Raid" by borrowing as many shares as we were able and dumping them back into the market.  

This had the desired effect of having the share price fall significantly and we were then able to cover our short by taking out stop loss orders and other sell orders from nervous shareholders scared by the rapid fall we engineered, thus covering our short and realizing a nice return on our little gambit.

********************

Mind you, if a PR like that does in fact come out...just remember, you read it here first at Avoid The Bag.  

Vuzix may have been the target of such a bear raid, there's no way to know.  It is after all an incredibly risky stock given the amount of money they're burning through as evidenced by their 20 year history and accumulated deficit of over $85 million up to June 30th of this year.  


Dilution is continually happening, after effecting a 1:75 reverse split share consolidation in February 2013 the number of issued shares was reduced to roughly 3.5 million as of May 15, 2013. But as of the most recent 10Q filing for the period up to June 30th the total outstanding shares had grown to over 20.6 million.  That was before yet another share offering for 1.5 million more shares.  

And then of course there is Intel which holds 49,626 shares of Series A Preferred Stock.  Each of those Series A Preferred shares is convertible into 100 common shares, meaning if Intel opts to convert and sell them, then there would be even more dilution to the tune of 4,962,600 more shares.  At this rate it might not be long before yet another reverse split is needed if they want to stay listed on the Nasdaq rather than going back to the OTCBB and Vancouver Exchange where they started.

Those who've already read the filings know the Pro Forma Book Value as of June 30th was only $0.71 per share of common stock, and just $0.44 cents on an as converted basis with the Series A convertible shares.  If you've missed that information you can get it from the filing here:


So what happened Thursday?  Was it hedge fund type games, or maybe Intel converting and disposing of its shares, or something else all together?  Who knows...but the fundamental picture remains scary to my eyes.  

I am aware that there are a lot of people seeing Rainbows and Unicorns in the future.  All I will say is wake me when the dream becomes reality, or maybe the Rainbow and Unicorn types are the ones who are asleep and dreaming.  

Comments always welcome, but no profanity...the word "hell" in the subject line of this posting is about as far as I will allow.  






Sunday, September 17, 2017

Resverlogix to attend BioPharm America 2017 Sept 26 and 27 in Boston

Resverlogix has posted to its website, on the Media Events page, that the company will be attending Biopharm America in Boston on September 26th and 27th of this year, just over a week from now. Look under "Current Events" about half way down the page:


Biopharm America is in its 10th year and is described as unique partnering event which brings together hundreds of executives from: Venture Capital, Major Pharma, Academia and all manner of Biotech Firms from start ups to developed companies with drugs on the market.

Biopharm America uses "PartneringOne" a software platform that allows participants to tailor one on one meetings specific to their needs.  The two day conference features leaders and executives from across the spectrum of Life Sciences.  Some big players slated to be in attendance include AstraZeneca, Bayer, Genentech, Merck, Pfizer and many more. 

As a Resverlogix shareholder who's very hopeful for the success of Apabetalone, the company's lead compound currently in Phase III trial, it is certainly encouraging to see the company busy and getting out to an event such as this one.  

BUT PLEASE TAKE NOTE, THERE IS A VERY REAL POSSIBILITY THE COMPANY MAY SKIP THE EVENT WITHOUT GIVING SHAREHOLDERS ANY NOTIFICATION!!!

I realize that might come as a shock to some, that a public company would publish on the world wide web its attendance at a major conference, and then not show up without prior notification.  But it is something that has already happened twice this year, most recently at the Rodman & Renshaw Investor Conference in New York City on September 11th.  The other time was in May at BioEquity Europe in Paris.  

In both cases the company published on their website attendance but then cancelled without providing any notification to shareholders ahead of the fact.  In the most recent case I communicated with IR at Resverlogix and was informed via email that the Rodman & Renshaw cancellation was due to a scheduling conflict, but no details were provided as to the nature of the conflict.  

I am pointing this out because if the company skips out again without prior notification I don't want my readers to accuse me of knowingly putting out false information.  I prefer to be proactive rather than reactive, and knowing the company's history of skipping investor conferences and such without notification I feel it behooves me to at least warn readers that it is a possibility.  

I am hopeful however that if, (for any reason) the company does decide to skip BioPharm America, that now they will notify stakeholders before the fact and not after.  I will be checking their media page frequently to see if the event is still listed and will leave a comment on this blog posting if I notice that it suddenly disappears.  

But to reiterate, I am hopeful the company will be proactive going forward.  I base that hope on a conversation I had with Resverlogix's VP of Investor Relations this past Friday. During that conversation I went through something of a laundry list of items where the company's communications were severely lacking in my view, some of it very basic stuff.  

On top of the two investor conferences that were skipped the company had published a Power Point with missing agenda items, and another with the wrong debt figure and share totals.  Then most recently on September 13th just passed the company put out a PR which said the company's most recent quarterly statements and MD&A were available on the company's website....they were not. Thankfully late on the afternoon of Friday September 16th, (after my conversation with IR) they were finally posted to the site.  Better late than never. 

IR acknowledged the importance of projecting a positive corporate image and of professionalism in the company's communications.  After all Resverlogix has a value statement on their website that says they're committed to "timely and transparent communications".  

Going forward I expect nothing less.